RxDoctor Payments Data

Candrice Heath

Dermatology · Washington, DCNPI 1346436052

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $125,365 of the $168,321 with a category attached, or 74.5%. 13 manufacturers reported payments, led by Johnson & Johnson at 27.2% of the total. Reporting peaked in 2024 at $85,530 and has fallen 92.5% since, to $6,432 in 2025. Among dermatology clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$168,321in general payments, 2019–2025

Across 142 payments — averaging $1185.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$46K
  • Lilly USA, LLC$30K
  • Eli Lilly$22K
  • Pfizer$22K
  • Arcutis Biotherapeutics, Inc.$13K
  • Janssen Scientific Affairs, LLC$10K
  • plus $26K from 7 others
$45,750in research payments, 2019–2025

Across 7 payments — averaging $6535.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$22K
  • Eli Lilly$22K
  • Pfizer$1K
  • Regeneron$1K

What the payments were for

  • Consulting fees$125,36574%
  • Speaking & faculty fees$31,75019%
  • Travel & lodging$8,2505%
  • Food & beverage$2,9552%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$168,321 in reported general payments places this provider in the 95th percentile of 73 dermatology providers in District of Columbia.

See all dermatology providers in District of Columbia

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate18$2,522

Paid to pharmacies, not to this prescriber.

Other dermatology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →